Operator O2 plans to acquire IT company Ness Czech
Published
Telecommunications operator O2 has announced its intention to acquire the Czech branch of the international IT company Ness. This transaction is now under review by the Office for the Protection of Competition (ÚOHS), which must assess whether the merger of the companies will affect the market environment in the Czech Republic.
Ness Czech has long focused on software development and the provision of IT services. The company has a strong presence in the Czech Republic, operating branches in Prague, Brno, and Ostrava. It currently employs more than 200 experts who participate in a number of technological projects.
According to available information, the company struggled with a decline in economic results over the last year. Its annual turnover in 2025 fell below the threshold of one billion Czech crowns. A connection with a large operator like O2 could mean new stability and opportunities for further development in the Czech market for the company.
The Office for the Protection of Competition is now analyzing all documents submitted by both parties. The office's decision will be crucial for whether the acquisition takes place. If the office approves the merger, Ness Czech will become part of the O2 group, which could significantly strengthen the operator's position in the field of IT services and digitalization.
Sources: ITBiz.cz
More Czechia news
- Aricoma is Dell Technologies' Partner of the Year
- Ethiopian aquaculture needs foreign technology and know-how
- Czechia ranks above the global average in children's physical activity
- Pavel receives Hungarian President Baka. According to him, both countries share a view on Europe's security
- Economic Chamber welcomes stricter fight against illegal employment
- Chase across half of the Czech Republic: police stopped one car, the other was found empty near Prague
- Adéla Knapová criticises Babiš and Okamura: Czechia is weak and defenceless, she says
- Cardiologists in Ústí became the first to use a modern system for treating cardiac arrhythmias